Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate symptoms control and impact on daily life from patients perspective using specific GERD Impact Scale(GIS) questionnaire. The another objective is to obtain local epidemiological data for Bosnia and Herzegovina regarding GERD treatment in primary care.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Epidemiological data: To assess frequency and severity of typical GERD symptoms in newly diagnosed GERD patients and GERD patients with disease duration =3 years | Maximum of 14 weeks, with 3 visits in total | |
| Epidemiological data: To assess frequency and severity of typical GERD symptoms in newly diagnosed GERD patients and GERD patients with disease duration =3 years | Visit 1 (enrolment) | |
| Epidemiological data: To assess frequency and severity of typical GERD symptoms in newly diagnosed GERD patients and GERD patients with disease duration =3 years | Visit 2 (4-6 weeks after Visit 1) | |
| Epidemiological data: To assess frequency and severity of typical GERD symptoms in newly diagnosed GERD patients and GERD patients with disease duration =3 years | Visit 3 (8-14 weeks after Visit 1). |
| Measure | Description | Time Frame |
|---|---|---|
| The evaluation of GERD Impact Scale (GIS questionnaire) as a useful tool for initial and long term management of GERD patients | Maximum of 14 weeks, with 3 visits in total: Visit 1 (enrolment), Visit 2 (4-6 weeks after Visit 1) and Visit 3 (8-14 weeks after Visit 1). |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients previously diagnosed with GERD (disease duration =3 years) or newly diagnosed patients that are currently not treted with proton pump inhibitors, for whom GP or specialist (in primary care unit) have previosly decided to initiate or change treatment for GERD.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Srdjan Gornjakovic, MD, PhD | Clinical Center University of Sarajevo; Department of Gastrenterology and HepatologySarajevo | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Banja Luka | Bosnia and Herzegovina | ||||
| Research Site |
Not provided
Not provided
Not provided
Not provided
| Bijeljina |
| Bosnia and Herzegovina |
| Research Site | Derventa | Bosnia and Herzegovina |
| Research Site | Doboj | Bosnia and Herzegovina |
| Research Site | Gračanica | Bosnia and Herzegovina |
| Research Site | Gradačac | Bosnia and Herzegovina |
| Research Site | Gradiska | Bosnia and Herzegovina |
| Research Site | Hadžići | Bosnia and Herzegovina |
| Research Site | Jelah | Bosnia and Herzegovina |
| Research Site | Laktasi | Bosnia and Herzegovina |
| Research Site | Lukavac | Bosnia and Herzegovina |
| Research Site | Lukavica | Bosnia and Herzegovina |
| Research Site | Matuzići | Bosnia and Herzegovina |
| Research Site | Mostar | Bosnia and Herzegovina |
| Research Site | Pale | Bosnia and Herzegovina |
| Research Site | Prijedor | Bosnia and Herzegovina |
| Research Site | Sarajevo | Bosnia and Herzegovina |
| Research Site | Trn | Bosnia and Herzegovina |
| Research Site | Tuzla | Bosnia and Herzegovina |
| Research Site | Visoko | Bosnia and Herzegovina |
| Research Site | Vogošća | Bosnia and Herzegovina |
| Research Site | Zalužani | Bosnia and Herzegovina |
| Research Site | Živinice | Bosnia and Herzegovina |
| ID | Term |
|---|---|
| D005764 | Gastroesophageal Reflux |
| ID | Term |
|---|---|
| D015154 | Esophageal Motility Disorders |
| D003680 | Deglutition Disorders |
| D004935 | Esophageal Diseases |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided